Kymera Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on February 22
February 15 2024 - 7:00AM
Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage
biopharmaceutical company advancing a new class of small molecule
medicines using targeted protein degradation (TPD), will report
fourth quarter and full year 2023 financial results on February 22,
2024, and will host a conference call at 8:30 a.m. ET.
To access the February 22 conference call via phone, please dial
+1 (833) 630-2127 (US) or +1 (412) 317-1846 (International) and ask
to join the Kymera Therapeutics call. A live webcast of the
Company’s conference call will be available under “News and Events”
in the Investors section of the Company’s website at
www.kymeratx.com. A replay of the webcast will be archived and
available following the event.
About Kymera TherapeuticsKymera is a
clinical-stage biotechnology company pioneering the field of
targeted protein degradation (TPD) to develop medicines that
address critical health problems and have the potential to
dramatically improve patients’ lives. Kymera is deploying TPD to
address disease targets and pathways inaccessible with conventional
therapeutics. Having advanced the first degrader into the clinic
for immunological diseases, Kymera is focused on delivering oral
small molecule degraders to provide a new generation of convenient,
highly effective therapies for patients with these conditions.
Kymera is also progressing degrader oncology programs that target
undrugged or poorly drugged proteins to create new ways to fight
cancer. Founded in 2016, Kymera has been recognized as one of
Boston’s top workplaces for the past several years. For more
information about our science, pipeline and people, please visit
www.kymeratx.com or follow us on X (previously Twitter) or
LinkedIn.
Investor
Contact: Justine KoenigsbergVice President,
Investor Relationsinvestors@kymeratx.com857-285-5300 |
Media
Contact: Todd Cooper Senior Vice
President, Corporate
Affairs media@kymeratx.com 857-285-5300 |
Kymera Therapeutics (NASDAQ:KYMR)
Historical Stock Chart
From Apr 2024 to May 2024
Kymera Therapeutics (NASDAQ:KYMR)
Historical Stock Chart
From May 2023 to May 2024